Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG
Status:
Unknown status
Trial end date:
2020-04-10
Target enrollment:
Participant gender:
Summary
Atrial fibrillation in the postoperative period of myocardial revascularization surgery
(AF-POMR) occurs in 10% to 65% of patients, increasing morbidity and mortality after surgery.
is associated with an increase in hospital length of stay, and, thus, in costs,and can cause
serious clinical complications, such as hypotension, heart failure, stroke and other
thromboembolic disorders.Although not completely understood, the electrophysiological
mechanism of AF-POMR is believed to be reentry.